estradiol, 25 mcg

Pre-clinicalCompleted
0 watching 0 views this week๐Ÿ’ค Quiet
22
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Menopause

Conditions

Menopause, Postmenopausal Vaginal Atrophy

Trial Timeline

Apr 1, 2006 โ†’ Nov 1, 2006

About estradiol, 25 mcg

estradiol, 25 mcg is a pre-clinical stage product being developed by Novo Nordisk for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT01507454. Target conditions include Menopause, Postmenopausal Vaginal Atrophy.

Hype Score Breakdown

Clinical
5
Activity
2
Company
9
Novelty
2
Community
1

Clinical Trials (3)

NCT IDPhaseStatus
NCT01507454Pre-clinicalCompleted
NCT00560924Phase 3Terminated
NCT00464971Phase 3Completed